Data / Federal awards / NAICS 541711 / PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD.
PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD.: 17 federal contract awards, $2.8 million obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD. (UEI MXP1NVQ8C1J8), New Taipei City, Taiwan, received 17 federal prime contract awards with $2.8 million obligated in fiscal years 2024 to 2027, from 1 agency under 2 NAICS codes. Its largest buyer is Department of Health and Human Services ($2.8 million) and its largest code is NAICS 541711 Research and Development in Biotechnology.
The request: Every federal contract awarded under NAICS 541711, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- UEI
- MXP1NVQ8C1J8
- Location
- New Taipei City, Taiwan
- Business size
- Other Than Small Business
- Contract awards
- 17
- Obligated
- $2.8 million
- First action in window
- 2023-10-24
- Latest action
- 2026-09-30
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541711 | Research and Development in Biotechnology | 13 | $1.4 million |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 4 | $1.3 million |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 17 | $2.8 million |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $1.3 million |
| FY2025 | $141,700 |
| FY2026 | $1.3 million |
Contract awards
All 17 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75N93026F00002 | Department of Health and Human Services | Delivery Order | 541714 | MOUSE MODEL OF NEISSERIA GONORRHOEAE INFECTION | $621,336 | $621,336 | July 22, 2026 | July 14, 2031 | Taiwan | usaspending.gov |
| 75N93023F00002 | Department of Health and Human Services | Delivery Order | 541711 | PRE-CLINICAL MODELS OF INFECTIOUS DISEASE | $554,966 | $1,239,019 | August 31, 2023 | February 7, 2025 | Taiwan | usaspending.gov |
| 75N93026F00003 | Department of Health and Human Services | Delivery Order | 541714 | THERAPEUTIC TESTING IN MURINE MODELS OF BACTERIAL INFECTION | $545,542 | $545,542 | September 30, 2026 | September 29, 2027 | Taiwan | usaspending.gov |
| 75N93024F00003 | Department of Health and Human Services | Delivery Order | 541711 | A94 - TESTING IN MURINE MODELS OF BACTERIAL INFECTION | $503,403 | $503,403 | July 10, 2024 | July 9, 2025 | Taiwan | usaspending.gov |
| 75N93024F00002 | Department of Health and Human Services | Delivery Order | 541711 | MOUSE MODEL OF NEISSERIA GONORRHOEAE INFECTION | $331,260 | $331,260 | July 12, 2024 | July 11, 2025 | Taiwan | usaspending.gov |
| 75N93023F00001 | Department of Health and Human Services | Delivery Order | 541711 | MURINE MODELS OF UTI INFECTION CAUSED BY ANTIBIOTIC-RESISTANT BACTERIA | $283,400 | $599,260 | July 19, 2023 | February 27, 2025 | Taiwan | usaspending.gov |
| 75N93026F00001 | Department of Health and Human Services | Delivery Order | 541714 | A12 - MURINE MODELS OF UTI INFECTION CAUSED BY ANTIBIOTIC-RESISTANT BACTERIA | $169,160 | $169,160 | July 15, 2024 | July 14, 2031 | Bethesda, MD | usaspending.gov |
| 75N93024D00017 | Department of Health and Human Services | IDC | 541714 | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES - TASK AREA A | $0 | $146,300,000 | July 15, 2024 | usaspending.gov | ||
| 75N93021F00003 | Department of Health and Human Services | Delivery Order | 541711 | PRECLINICAL MODELS OF INFECTIOUS DISEASES | $-1 | $1,170,062 | September 7, 2021 | July 30, 2023 | Taiwan | usaspending.gov |
| 75N93019F00131 | Department of Health and Human Services | Delivery Order | 541711 | THERAPEUTIC TESTING IN MURINE MODELS OF BACTERIAL THIGH, LUNG AND PERITONITIS INFECTIONS A-32 | $-1,750 | $652,380 | July 1, 2019 | June 30, 2020 | Taiwan | usaspending.gov |
| 75N93022F00003 | Department of Health and Human Services | Delivery Order | 541711 | PCMID IDIQ | $-7,800 | $1,197,620 | August 12, 2022 | August 11, 2023 | Taiwan | usaspending.gov |
| 75N93022F00002 | Department of Health and Human Services | Delivery Order | 541711 | PCMID TASK AREA A67 | $-9,220 | $288,577 | May 16, 2022 | May 17, 2023 | Taiwan | usaspending.gov |
| 75N93021F00002 | Department of Health and Human Services | Delivery Order | 541711 | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES- THERAPEUTIC TESTING IN MURINE MODELS OF BACTERIAL INFECTION | $-14,440 | $952,930 | August 10, 2021 | August 9, 2022 | Taiwan | usaspending.gov |
| 75N93020F00159 | Department of Health and Human Services | Delivery Order | 541711 | TASK A42 THERAPEUTIC TESTING IN MURINE MODELS OF BACTERIAL THIGH, LUNG AND PERITONITIS INFECTIONS | $-17,100 | $933,804 | July 9, 2020 | July 31, 2021 | Taiwan | usaspending.gov |
| 75N93021F00001 | Department of Health and Human Services | Delivery Order | 541711 | TO AWARD BASE CONTRACT FOR PCMID PROJECT. | $-23,988 | $336,528 | January 22, 2021 | January 24, 2022 | Taiwan | usaspending.gov |
| 75N93018F00003 | Department of Health and Human Services | Delivery Order | 541711 | A-10 ""MURINE MODELS OF LUNG INFECTION - ANTIBIOTIC-RESISTANT PSEUDOMONAS AERUGINOSA" | $-51,585 | $506,429 | June 5, 2018 | August 15, 2023 | Rockville, MD | usaspending.gov |
| 75N93020F00001 | Department of Health and Human Services | Delivery Order | 541711 | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES | $-101,604 | $332,878 | September 2, 2020 | September 1, 2021 | Taiwan | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541711 Research and Development in Biotechnology
- All recipients under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Open opportunities under NAICS 541714
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.